EpigenCare has been announced as one of two winners who snatched the top spot in Johnson & Johnson’s Digital QuickFire Challenge.
The New York-based company will release its direct-to-consumer test later this year, which indicates the quality of users' skin, such as ageing, elasticity, moisture and pigmentation.
The solution is designed to measure whether or not a skin care product is working for the user.
Co-founder and CEO William Lee presented the innovation at Johnson & Johnson Innovation’s JLabs in San Francisco, California.
He said: “I am grateful for the opportunity that we have been provided.
“We intend to use this victory to continue our momentum in realising a truly personalised skin care solution.”
With data security being a global consumer concern, EpigenCare has deployed blockchain technology to manage the information collected.
Users will be able to track that their data was used for their own benefit, to mitigate the perceived intrusiveness often associated with personal tests involving DNA.
